Clinical Jeopardy: Addressing the MRSA Challenge!
Medium: Webcast On-Demand
Release Date: Tuesday, January 26, 2010
Credit Expiration Date: Wednesday, January 26, 2011
Physician CME: 2.0
Physician Assistants Hours: 2.0
Pharmacists CPE: 2.0
This online activity is based on the continuing education symposium which was held following
the official programming at the 47th Annual Meeting of IDSA in Philadelphia, Pennsylvania.
Clinical Jeopardy: Addressing the MRSA Challenge! Webcast is an educational activity that incorporates
the Clinical Jeopardy format to fully engage participants and enhance learning.
This activity consists of an Introduction on the MRSA challenge with a patient
case presented by Dr. Nicolau. Following Dr. Nicolau's introduction, participant
can choose to participate in three Clinical Jeopardy categories. Within each
category, participant can choose 3 different MRSA topics:
- MRSA Epidemiology and Mechanisms of Resistance - Donald Low, MD.
- MRSA Evolving Epidemiology
- Community-Associated MRSA
- Isolates with Decreased Susceptibility to Vancomycin: VRSA, VISA, hVISA
- Treatment Strategies for MRSA Infections - Vance Fowler, MD
- MRSA Skin Infections
- Bloodstream Infections
- Hospital-Acquired Pneumonia
Note: If you have received credit by attending the live symposium or simulcast by the same name, you
are not eligible to apply for credit for this online version.
- Importance of an Interdisciplinary Approach - David Nicolau, PharmD
- Antimicrobial Stewardship
- Optimizing Vancomycin Use
- Identifying the Right Patient for OPAT
Practice Gap and Educational Need
MRSA now accounts for approximately 50% of all S. aureus infections and is becoming more
prevalent in the community and hospital settings. Recent evidence suggests a blurring
distinction between community-associated and healthcare-associated MRSA strains, a finding
that can have major implications for epidemiology, infection control, and antimicrobial selection.
Vancomycin remains a common first-line choice for these infections. However, a growing prevalence
of strains with reduced susceptibility to vancomycin has emphasized the necessity for optimal
dosing of this agent or utilization of alternative agents. A better understanding of these issues
by clinicians can lead to optimal clinical outcomes while minimizing the economic burden of these infections.
An important first step has been taken with a steep rise in MRSA awareness among physicians,
pharmacists, and nurses, but uncertainty continues to exist regarding:
Positive outcomes can be achieved through continued education to all stakeholders in
order to reach a common understanding of these issues and to work together efficiently to resolve them.
- What are the new and evolving mechanisms of resistance and how do these impact therapeutic choices?
- What constitutes appropriate therapy in the face of blurring distinction between
community-associated and healthcare-associated MRSA infections?
- What is the appropriate role for ID physician, ID pharmacist, microbiologist, and epidemiologist
in managing infections due to MRSA?
- How can we best utilize outpatient parenteral antimicrobial therapy (OPAT) in treating MRSA infections?
This activity has been designed to meet the needs of ID physicians, epidemiologists,
ID surgeons, ER physicians, clinical pharmacists, and all healthcare professionals who care for
patients with serious infections and who may be involved in the diagnosis, management, and treatment
of patients with infections caused by MRSA.
Those healthcare professionals participating in this educational activity will be able at its
- Provide an update on epidemiology associated with infections due to MRSA.
- Differentiate the clinical spectrum of infections associated with CA-MRSA and HA-MRSA.
- Discuss effective treatment strategies for infections caused by MRSA.
- Identify patients who are likely to benefit from outpatient parenteral antimicrobial therapy.
Clinical Jeopardy Faculty
David P. Nicolau, PharmD, FCCP, FIDSA
Director, Center for Anti-Infective Research and Development
Donald E. Low, MD, FRCPC
University Health Network/Mount Sinai Hospital
Medical Director, Public Health Laboratories
Ontario Agency for Health Protection and Promotion
Vance G. Fowler, Jr., MD, MHS
Department of Medicine
Division of Infectious Diseases
Duke University Medical Center
Durham, North Carolina
Accreditation Statement: This activity has been planned and implemented in accordance with
the Essential Areas and Policies of the Accreditation Council for Continuing Medical
Education (ACCME) through joint sponsorship of Center for Independent Healthcare
Education (Center) and Vemco MedEd. Center is accredited by the ACCME to provide continuing
medical education for physicians.
Credit Designation: Center designates for this activity a maximum of 2.0 AMA PRA Category 1 Credits™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Academy of Physician Assistants accepts certificates of participation for educational activities
certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME. Physician assistants
may receive a maximum of 2.0 hours of Category I credit for completing this activity.
Center for Independent Healthcare Education (Center) is accredited by the Accreditation Council for
Pharmacy Education as a provider of continuing pharmacy education. Center has assigned 2.0 contact
hours (0.2 CEUs) of continuing pharmacy education credit for participation in this activity.
ACPE Universal Activity Number: 0473-9999-10-001-H01-P
Type of Activity: Knowledge-based
For questions regarding the accreditation of this activity, please contact Center at firstname.lastname@example.org.
Method of Participation and Instruction for Credit
Review the entire CME information including target audience, learning objectives, and disclosures.
Documentation of credit will be mailed within 4 weeks of receipt of the completed Self-Assessment, Evaluation, and Credit Application form.
- Review the four learning modules in their entirety.
- Print and complete the Self-Assessment, Evaluation, and Credit Application form.
- Mail the completed Self-Assessment, Evaluation, and Credit Application form to Vemco MedEd, 245 US Highway 22, Suite 304, Bridgewater, NJ 08807 or fax to (908) 450-3300.
Disclosure of Conflicts of Interest
Center for Independent Healthcare Education requires faculty, planners, and others who are in a position to
control the content of continuing education activities to disclose to the audience any real or apparent
conflict of interest related to the activity. All identified conflicts of interest are reviewed to ensure
fair balance, objectivity, and scientific rigor in all activities. The faculty is further required to
disclose discussion of off-label uses in their presentations.
David P. Nicolau, PharmD, FCCP, FIDSA serves on the advisory board for AstraZeneca, Cubist, Wyeth,
Pfizer, Ortho-McNeil, and Merck. He receives grant/research support and serves in the speakers
bureaus of AstraZeneca, Ortho-McNeil, Cubist, Wyeth, Merck, Pfizer, and Theravance.
Donald E. Low, MD, FRCPC serves on the advisory board as a consultant for Boehringer Ingelheim
USA Corporation. He receives grant/research support from Bayer Healthcare AG, Cerexa, and
GlaxoSmithKline as Principal Investigator.
Vance G. Fowler, Jr., MD, MHS serves as a consultant for Inhibitex, Arpida, Inimex, Cubist, and
Merck. He has received research/grant support from Astellas, Merck, Cerexa and Theravance.
Planning Committee Members
Employees of Center for Independent Healthcare Education and Vemco MedEd have no relevant financial relationships to disclose.
Disclosure of Off-label Use
During this activity, the following off-label uses of the following antimicrobial agents will be
discussed: tigecycline (for the treatment of hospital-acquired pneumonia); telavancin (for the treatment
of hospital-acquired pneumonia); dalbavancin, oritavancin, iclaprim, ceftobiprole, and ceftaroline
(for the treatment of skin infections caused by methicillin-resistant Staphylococcus aureus).
This activity is jointly sponsored by Center for Independent Healthcare Education and Vemco MedEd.
This activity is supported by an educational grant from Astellas Pharma US, Inc.
There is no fee associated with this activity.
Microsoft Internet Explorer or Mozilla Firefox
Note: Please disable any “pop-up blocker” features.
Adobe® Flash® Player to view the presentations (If you do not have Adobe® Flash® Player, you can
download it for free from get.adobe.com/flashplayer)
Adobe Acrobat Reader version 4 or above to view PDF files (If you do not have Acrobat Reader, you can download it
for free from get.adobe.com/reader)
Cable, DSL, or better of at least 300 kbps
PC or Macintosh to view the presentations
Please e-mail any questions or concerns to email@example.com.
Copyright © 2010 Vemco MedEd, LLC. All Rights Reserved.
Permission for accreditation use granted to Center for Independent Healthcare Education.
The opinions expressed in this educational activity are those of the faculty and do not reflect the views of
Center for Independent Healthcare Education (Center) and Vemco MedEd. This educational activity may discuss
off-label and/or investigational uses and dosages for therapeutic products/procedures that have not been
approved by the United States Food and Drug Administration (FDA). Center and Vemco MedEd do not recommend the
use of any product/procedure outside of the labeled indications. A qualified healthcare professional should be
consulted before using any therapeutic product/procedure discussed. Clinicians should verify all information and
data before treating patients or employing any therapies described in this continuing education activity. Please
refer to the prescribing information for each product/procedure for approved
indication, contraindications, and warnings.
For questions regarding the accreditation of this activity, please contact Center for Independent Healthcare
Education at firstname.lastname@example.org
This activity consists of an Introduction on the MRSA challenge with a patient case presented
by Dr. Nicolau. Following Dr. Nicolau's introduction, the computer screen will automatically
be promoted to a Jeopardy board. The participant can choose to listen to any of the nine
topics within the three Jeopardy categories
By clicking on the icon to begin the educational activity, I acknowledge that I have read the entire CME/CE information.